Methotrexate shows marginal clinical efficacy in early scleroderma John Varga Clinical Trials Report Pages: 97 - 98
The genetics of systemic sclerosis Randall W. JohnsonMonty B. TewFrank C. Arnett OriginalPaper Pages: 99 - 107
Evaluation and management of pulmonary fibrosis in scleroderma Barbara White OriginalPaper Pages: 108 - 112
Scleroderma-like cutaneous syndromes Yasuji MoriVeli-Matti KahariJohn Varga OriginalPaper Pages: 113 - 122
Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis Eugene KissinJoseph H. Korn OriginalPaper Pages: 129 - 135
Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis Andrew LeaskAlan HolmesDavid J. Abraham OriginalPaper Pages: 136 - 142
Control of connective tissue gene expression by TGFβ: Role of smad proteins in fibrosis Franck VerrecchiaAlain Mauviel OriginalPaper Pages: 143 - 149
Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy Mishaela R. RubinShonni J. Silverberg OriginalPaper Pages: 179 - 185